My Treatment Approach: Translating Evidence to Clinical Practice in Advanced RCC   - Episode 16

Summary and Forward Looking for RCC

In her concluding remarks, Laurence Albiges, MD, PhD, shares her final thoughts and expresses optimism for the future landscape of renal cell carcinoma treatments.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Evolving Treatment Standards in Non-Clear Cell RCC
    EP. 2: Extended Follow Up of KEYNOTE-B61
    EP. 3: Ongoing Clinical Trials in the front-line setting of advanced non-clear cell RCC
    EP. 4: STELLAR 304: Zanzalintinib plus nivolumab in non-clear cell RCC
    EP. 5: Case Presentation: 61-year-old male Renal Cell Carcinoma
    EP. 6: Use of Combination Regimens in Frontline RCC
    EP. 7: Treatment Decision Making in first-line combinations for advanced RCC
    EP. 8: AE Management for Combination Regimens in Advanced RCC
    EP. 9: AE Management for Combination Regimens in Advanced RCC
    EP. 10: Optimizing Treatment in Advanced RCC
    EP. 11: Dr Albiges Discusses a Non-Clear Cell RCC Patient Profile
    EP. 12: Updates in the Treatment Approach for Non-clear cell RCC
    EP. 13: Dr Albiges Reviews Long term follow up data from KEYNOTE-B61
    EP. 14: Emerging Therapies in the Front-line Setting of Advanced non-clear cell RCC
    EP. 15: Biomarker-driven combination treatment approach in non-clear cell RCC (Met-driven)
    Now Viewing
    EP. 16: Summary and Forward Looking for RCC

    x